Imagine a fighter delivering a performance so impressive that UFC President Dana White personally thanks him for ‘making his night,’ only to have that victory overshadowed by a failed drug test. That’s exactly what happened to Levi Rodrigues, whose future in the UFC is now hanging by a thread. But here’s where it gets controversial: Was this a genuine mistake, or a costly oversight that could derail a promising career? Let’s dive in.
This year’s season of Dana White’s Contender Series was nothing short of electrifying, showcasing unforgettable moments and introducing fresh talent to the UFC roster. Among the highlights was a fight between Adrian Luna Martinetti and Mark Vologdin, widely hailed as one of the greatest in the show’s history. But it was Juan Diaz’s jaw-dropping spinning elbow knockout of Kwon Won Il that left White—and the entire audience—stunned. Yet, while Diaz’s moment was a personal highlight for the UFC president, it’s Rodrigues’s story that has taken an unexpected turn.
Rodrigues earned his UFC contract after stopping Freddy Vidal in the first round during his second appearance on the Contender Series. White was particularly impressed, thanking Rodrigues for preventing what could have been a dull, strategy-heavy fight. ‘You made my night,’ White declared as he awarded the contract. But now, that victory is in jeopardy after Rodrigues’s manager, Lucas Lutkus, revealed to MMA Junkie that the fighter tested positive for nandrolone, a prohibited substance.
And this is the part most people miss: Lutkus claims the positive test stems from Rodrigues’s use of nandrolone to treat a back injury in 2024—a treatment he reportedly stopped a year before his Contender Series bout. ‘Levi has no prior history of anti-doping violations and has never failed a drug test,’ Lutkus stated. ‘He respects the NSAC process and will fully comply with all requirements moving forward.’ But will this explanation be enough to save his UFC career?
The situation raises a broader question: Should fighters like Rodrigues be permanently banned for failed drug tests, or is there room for nuance? Take Antonio Trocoli, for instance, who had to win another fight to secure his UFC spot after his Contender Series victory was overturned. Conversely, Josh Quinlan and Lukasz Brezeski retained their contracts despite similar failed tests. Is consistency too much to ask, or is each case truly unique?
As Rodrigues’s win over Vidal is likely to be overturned to a no contest, the bigger question looms: Will he lose his hard-earned spot on the UFC roster? This isn’t just about one fighter’s future—it’s about the integrity of the sport and how the UFC handles such controversies. What do you think? Should Dana White take a zero-tolerance approach, or is there room for second chances? Let us know in the comments below. Join the debate—your insight could spark the next big conversation in the MMA world.
